Oncology & Cancer
HOXA9 tracking reveals RBM5 dual function and therapeutic potential for acute myeloid leukemia
The protein HOXA9 is overexpressed in most acute myeloid leukemia (AML) cases and is associated with poor patient outcomes. However, HOXA9 is a difficult protein to target therapeutically, so researchers at St. Jude Children's ...
Jan 12, 2024
0
0
